Global Omalizumab Biosimilars Market Research Report 2023(Status and Outlook)
- Published Date: 2023-08-20
- Report ID: 146049
- Pages: 250
-
Format:
Report Overview
Omalizumab is a medication used to treat asthma, nasal polyps, and urticaria. Omalizumab is a recombinant DNA-derived humanized IgG1k monoclonal antibody that specifically binds to free human immunoglobulin E (IgE) in the blood and interstitial fluid and to membrane-bound form of IgE (mIgE) on the surface of mIgE-expressing B lymphocytes. Unlike an ordinary anti-IgE antibody, it does not bind to IgE that is already bound by the high affinity IgE receptor (FcRI) on the surface of mast cells, basophils, and antigen-presenting dendritic cells.
Prudent Markets latest report provides a deep insight into the global Omalizumab Biosimilars market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Omalizumab Biosimilars Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Omalizumab Biosimilars market in any manner.
Global Omalizumab Biosimilars Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Novartis
Glenmark Pharmaceuticals
Selexis
Generium
CuraTeQ
Celltrion Healthcare
Alvotech
BiosanaPharma
Mabpharm
CSPC Pharmaceutical Group
Biomabs
HisunPharm
Grand Pharm
Market Segmentation (by Type)
150 mg/mL
75 mg/0.5 mL
Market Segmentation (by Application)
Persistent Asthma
Nasal Polyps
Chronic Idiopathic Urticaria
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Omalizumab Biosimilars Market
Overview of the regional outlook of the Omalizumab Biosimilars Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Omalizumab Biosimilars Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Omalizumab Biosimilars
1.2 Key Market Segments
1.2.1 Omalizumab Biosimilars Segment by Type
1.2.2 Omalizumab Biosimilars Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Omalizumab Biosimilars Market Overview
2.1 Global Market Overview
2.1.1 Global Omalizumab Biosimilars Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Omalizumab Biosimilars Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Omalizumab Biosimilars Market Competitive Landscape
3.1 Global Omalizumab Biosimilars Sales by Manufacturers (2018-2023)
3.2 Global Omalizumab Biosimilars Revenue Market Share by Manufacturers (2018-2023)
3.3 Omalizumab Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Omalizumab Biosimilars Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Omalizumab Biosimilars Sales Sites, Area Served, Product Type
3.6 Omalizumab Biosimilars Market Competitive Situation and Trends
3.6.1 Omalizumab Biosimilars Market Concentration Rate
3.6.2 Global 5 and 10 Largest Omalizumab Biosimilars Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Omalizumab Biosimilars Industry Chain Analysis
4.1 Omalizumab Biosimilars Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Omalizumab Biosimilars Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Omalizumab Biosimilars Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Omalizumab Biosimilars Sales Market Share by Type (2018-2023)
6.3 Global Omalizumab Biosimilars Market Size Market Share by Type (2018-2023)
6.4 Global Omalizumab Biosimilars Price by Type (2018-2023)
7 Omalizumab Biosimilars Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Omalizumab Biosimilars Market Sales by Application (2018-2023)
7.3 Global Omalizumab Biosimilars Market Size (M USD) by Application (2018-2023)
7.4 Global Omalizumab Biosimilars Sales Growth Rate by Application (2018-2023)
8 Omalizumab Biosimilars Market Segmentation by Region
8.1 Global Omalizumab Biosimilars Sales by Region
8.1.1 Global Omalizumab Biosimilars Sales by Region
8.1.2 Global Omalizumab Biosimilars Sales Market Share by Region
8.2 North America
8.2.1 North America Omalizumab Biosimilars Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Omalizumab Biosimilars Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Omalizumab Biosimilars Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Omalizumab Biosimilars Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Omalizumab Biosimilars Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche
9.1.1 Roche Omalizumab Biosimilars Basic Information
9.1.2 Roche Omalizumab Biosimilars Product Overview
9.1.3 Roche Omalizumab Biosimilars Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Omalizumab Biosimilars SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Novartis
9.2.1 Novartis Omalizumab Biosimilars Basic Information
9.2.2 Novartis Omalizumab Biosimilars Product Overview
9.2.3 Novartis Omalizumab Biosimilars Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Omalizumab Biosimilars SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Glenmark Pharmaceuticals
9.3.1 Glenmark Pharmaceuticals Omalizumab Biosimilars Basic Information
9.3.2 Glenmark Pharmaceuticals Omalizumab Biosimilars Product Overview
9.3.3 Glenmark Pharmaceuticals Omalizumab Biosimilars Product Market Performance
9.3.4 Glenmark Pharmaceuticals Business Overview
9.3.5 Glenmark Pharmaceuticals Omalizumab Biosimilars SWOT Analysis
9.3.6 Glenmark Pharmaceuticals Recent Developments
9.4 Selexis
9.4.1 Selexis Omalizumab Biosimilars Basic Information
9.4.2 Selexis Omalizumab Biosimilars Product Overview
9.4.3 Selexis Omalizumab Biosimilars Product Market Performance
9.4.4 Selexis Business Overview
9.4.5 Selexis Omalizumab Biosimilars SWOT Analysis
9.4.6 Selexis Recent Developments
9.5 Generium
9.5.1 Generium Omalizumab Biosimilars Basic Information
9.5.2 Generium Omalizumab Biosimilars Product Overview
9.5.3 Generium Omalizumab Biosimilars Product Market Performance
9.5.4 Generium Business Overview
9.5.5 Generium Omalizumab Biosimilars SWOT Analysis
9.5.6 Generium Recent Developments
9.6 CuraTeQ
9.6.1 CuraTeQ Omalizumab Biosimilars Basic Information
9.6.2 CuraTeQ Omalizumab Biosimilars Product Overview
9.6.3 CuraTeQ Omalizumab Biosimilars Product Market Performance
9.6.4 CuraTeQ Business Overview
9.6.5 CuraTeQ Recent Developments
9.7 Celltrion Healthcare
9.7.1 Celltrion Healthcare Omalizumab Biosimilars Basic Information
9.7.2 Celltrion Healthcare Omalizumab Biosimilars Product Overview
9.7.3 Celltrion Healthcare Omalizumab Biosimilars Product Market Performance
9.7.4 Celltrion Healthcare Business Overview
9.7.5 Celltrion Healthcare Recent Developments
9.8 Alvotech
9.8.1 Alvotech Omalizumab Biosimilars Basic Information
9.8.2 Alvotech Omalizumab Biosimilars Product Overview
9.8.3 Alvotech Omalizumab Biosimilars Product Market Performance
9.8.4 Alvotech Business Overview
9.8.5 Alvotech Recent Developments
9.9 BiosanaPharma
9.9.1 BiosanaPharma Omalizumab Biosimilars Basic Information
9.9.2 BiosanaPharma Omalizumab Biosimilars Product Overview
9.9.3 BiosanaPharma Omalizumab Biosimilars Product Market Performance
9.9.4 BiosanaPharma Business Overview
9.9.5 BiosanaPharma Recent Developments
9.10 Mabpharm
9.10.1 Mabpharm Omalizumab Biosimilars Basic Information
9.10.2 Mabpharm Omalizumab Biosimilars Product Overview
9.10.3 Mabpharm Omalizumab Biosimilars Product Market Performance
9.10.4 Mabpharm Business Overview
9.10.5 Mabpharm Recent Developments
9.11 CSPC Pharmaceutical Group
9.11.1 CSPC Pharmaceutical Group Omalizumab Biosimilars Basic Information
9.11.2 CSPC Pharmaceutical Group Omalizumab Biosimilars Product Overview
9.11.3 CSPC Pharmaceutical Group Omalizumab Biosimilars Product Market Performance
9.11.4 CSPC Pharmaceutical Group Business Overview
9.11.5 CSPC Pharmaceutical Group Recent Developments
9.12 Biomabs
9.12.1 Biomabs Omalizumab Biosimilars Basic Information
9.12.2 Biomabs Omalizumab Biosimilars Product Overview
9.12.3 Biomabs Omalizumab Biosimilars Product Market Performance
9.12.4 Biomabs Business Overview
9.12.5 Biomabs Recent Developments
9.13 HisunPharm
9.13.1 HisunPharm Omalizumab Biosimilars Basic Information
9.13.2 HisunPharm Omalizumab Biosimilars Product Overview
9.13.3 HisunPharm Omalizumab Biosimilars Product Market Performance
9.13.4 HisunPharm Business Overview
9.13.5 HisunPharm Recent Developments
9.14 Grand Pharm
9.14.1 Grand Pharm Omalizumab Biosimilars Basic Information
9.14.2 Grand Pharm Omalizumab Biosimilars Product Overview
9.14.3 Grand Pharm Omalizumab Biosimilars Product Market Performance
9.14.4 Grand Pharm Business Overview
9.14.5 Grand Pharm Recent Developments
10 Omalizumab Biosimilars Market Forecast by Region
10.1 Global Omalizumab Biosimilars Market Size Forecast
10.2 Global Omalizumab Biosimilars Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Omalizumab Biosimilars Market Size Forecast by Country
10.2.3 Asia Pacific Omalizumab Biosimilars Market Size Forecast by Region
10.2.4 South America Omalizumab Biosimilars Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Omalizumab Biosimilars by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Omalizumab Biosimilars Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Omalizumab Biosimilars by Type (2024-2029)
11.1.2 Global Omalizumab Biosimilars Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Omalizumab Biosimilars by Type (2024-2029)
11.2 Global Omalizumab Biosimilars Market Forecast by Application (2024-2029)
11.2.1 Global Omalizumab Biosimilars Sales (K MT) Forecast by Application
11.2.2 Global Omalizumab Biosimilars Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
